New Kaiser analy­sis shows how lim­it­ing price ne­go­ti­a­tions to tar­get­ed drugs may bet­ter fo­cus up­com­ing leg­is­la­tion

As Con­gress con­sid­ers whether to adopt sweep­ing new leg­is­la­tion to low­er pre­scrip­tion drug prices across the board, the Kaiser Fam­i­ly Foun­da­tion is out with a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER